Amiodarone Therapy After Previous Sotalol-induced Torsade de Pointes: Analysis of QT Dispersion to Predict Proarrhythmia

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 1, Issue 1, 1996, Pages 75-78

  Van de Loo, Andreas ^a   Klingenheben, Thomas ^a   Hohnloser, Stefan H ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

class III antiarrhythmic drugs; QT dispersion; torsade de pointes

Indexed keywords

EID: 84992827699     PISSN: 10742484     EISSN: None     Source Type: Journal    
DOI: 10.1177/107424849600100111     Document Type: Article

References (22)

1. Jackman WM, Friday KJ, Anderson JL, Aliot EM, Clark M., Lazarra R. The long QT syndromes: A critical review, new clinical observations and a unifying hypothesis. Progr Cardiovasc Dis 31: 115, 1988
2. Haverkamp W., Shenasa M., Borggrefe M., Breithardt G. Torsades de pointes. In Zipes DP, Jalife J (eds). Cardiac Electrophysiology. WB Saunders, Philadelphia, pp. 885-899, 1994
3. Hohnloser SH, Arendts W., Quart B. Incidence, type, and dose-dependence of proarrhythmic events during sotalol therapy in patients treated for sustained VT/VF. Pace 15: 173, 1992
4. Hohnloser SH, Klingenheben T., Singh BN Amiodarone-associated proarrhythmic effects: A review with special reference to torsade de pointes tachycardia. Ann Intern Med 121: 529, 1994
5. Surawicz B., Knoebel SB Long QT: Good, bad, or indifferent ? J Am Coll Cardiol 4: 398, 1984
6. Singh BN When is QT prolongation antiarrhythmic and when is it proarrhythmic? Am J Cardiol 63: 867, 1988
7. Han J., Moe GK Nonuniform recovery of excitability in ventricular muscle. Circ Res 14: 44, 1964
8. Han J., Millet D., Chizzonitti B., Moe GK Temporal dispersion of recovery of excitability in atrium and ventricle as a function of heart rate. Am Heart J 71: 481, 1966
9. Merx W., Yoon MS, Han J. The role of local disparity in conduction and recovery time on ventricular vulnerability to fibrillation. Am Heart J 94: 603, 1977
10. Kuo CS, Munakata K., Reddy CP, Surawicz B. Characteristics and possible mechanism of ventricular arrhythmia dependent on the dispersion of action potential durations. Circulation 67: 1356, 1983
11. Day CP, McComb JM, Campbell Rwf. QT dispersion: An indication of arrhythmia risk in patients with long QT intervals. Br Heart J 63: 342, 1990
12. Day CP, McComb JM, Campbell Rwf. QT dispersion in sinus beats and ventricular extrasystoles in normal hearts. Br Heart J 67: 39, 1992
13. van de Loo A., Arendts W., Hohnloser SH Variability of QT dispersion measurements in the surface electrocardiogram in patients with acute myocardial infarction and in normal subjects. Am J Cardiol 74: 1113, 1994
14. Bazett HC An analysis of the time relations of electrocardiograms. Heart 7: 353, 1920
15. Linker NJ, Colonna P., Kekwick CA, Till J., Camm AJ, Ward DE Assessment of QT dispersion in symptomatic patients with congenital long QT syndromes. Am J Cardiol 69: 634, 1992
16. Priori SG, Napolitano C., Diehl L., Schwartz PJ Dispersion of the QT interval: A marker of therapeutic efficacy in the long QT syndrome. Circulation 89: 1681, 1994
17. Hii Jty, Wyse GD, Gillis AM, Duff HJ, Solylo MA, Mitchell BL Precordial QT interval dispersion as a marker of torsade de pointes. Circulation 86: 1376, 1992
18. Hohnloser SH, van de Loo A., Kalusche D., Arendts W., Quart B. Does sotalol-induced alteration of QT dispersion predict drug effectiveness or proarrhythmic hazards? Circulation 88(Suppl):1, 1993
19. Nguyen PT, Scheinman MM, Seger J. Polymorphous ventricular tachycardia: clinical characterization, therapy, and the QT interval. Circulation 74: 340, 1986
20. Mattioni TA, Zheutlin TA, Sarmiento JJ, Parker M., Lesch M., Kehoe RF Amiodarone in patients with previous drug-mediated torsade de pointes. Ann Intern Med 111: 574, 1989
21. Nattel S., Talajic M., Quantz M., DeRoode M. Frequency-dependent effects of amiodarone on atrioventricular nodal function and slow-channel action potentials: Evidence for calcium channel blocking activity. Circulation 76: 442, 1987
22. Hondeghem LM, Snyders DJ Class III antiarrhythmic agents have a lot of potential but a long way to go: Reduced effectiveness and dangers of reverse use dependence. Circulation 81: 686, 1990